AAMU
JAZZ icon

Amundi Asset Management US’s Jazz Pharmaceuticals JAZZ Stock Holding History

Amundi Asset Management US’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$16M Buy
97,625
+38,380
+65% +$6.32M 0.01% 728
2020
Q4 		$9.78M Sell
59,245
-7,644
-11% -$1.14M 0.01% 815
2020
Q3 		$9.54M Buy
66,889
+7,411
+12% +$919K 0.01% 747
2020
Q2 		$6.56M Buy
59,478
+8,013
+16% +$886K 0.01% 805
2020
Q1 		$5.13M Sell
51,465
-107,252
-68% -$13.9M 0.01% 731
2019
Q4 		$23.7M Buy
158,717
+18,559
+13% +$2.53M 0.03% 504
2019
Q3 		$18M Sell
140,158
-150,126
-52% -$20.1M 0.03% 541
2019
Q2 		$41.4M Sell
290,284
-120,710
-29% -$16.2M 0.03% 370
2019
Q1 		$58.8M Buy
410,994
+39,812
+11% +$5.19M 0.08% 247
2018
Q4 		$46K Buy
371,182
+147,419
+66% +$21.9M 0.04% 270
2018
Q3 		$37.6M Sell
223,763
-24,687
-10% -$4.25M 0.05% 350
2018
Q2 		$42.8M Sell
248,450
-185,561
-43% -$30.3M 0.06% 315
2018
Q1 		$65.5M Sell
434,011
-215,508
-33% -$31.6M 0.11% 206
2017
Q4 		$87.5M Sell
649,519
-241,803
-27% -$33.5M 0.13% 171
2017
Q3 		$130M Buy
891,322
+54,895
+7% +$8.3M 0.42% 74
2017
Q2 		$130M Buy
836,427
+127,551
+18% +$19.5M 0.43% 63
2017
Q1 		$103M Sell
708,876
-113,811
-14% -$14.8M 0.35% 79
2016
Q4 		$89.7M Buy
822,687
+178,904
+28% +$19.9M 0.32% 79
2016
Q3 		$78.2M Buy
643,783
+171,694
+36% +$23.1M 0.28% 86
2016
Q2 		$66.7M Buy
472,089
+9,629
+2% +$1.42M 0.24% 98
2016
Q1 		$60.4M Buy
462,460
+98,661
+27% +$12.3M 0.22% 100
2015
Q4 		$51.1M Buy
363,799
+29,151
+9% +$4.04M 0.19% 121
2015
Q3 		$44.4M Buy
334,648
+12,324
+4% +$2.12M 0.18% 134
2015
Q2 		$56.8M Sell
322,324
-608
-0.2% -$109K 0.21% 132
2015
Q1 		$55.8M Buy
322,932
+69,089
+27% +$11.9M 0.2% 127
2014
Q4 		$41.6M Sell
253,843
-57,161
-18% -$9.49M 0.15% 167
2014
Q3 		$49.9M Sell
311,004
-588
-0.2% -$90.4K 0.19% 144
2014
Q2 		$45.8M Buy
311,592
+42,923
+16% +$5.95M 0.18% 160
2014
Q1 		$37.3M Buy
268,669
+26,842
+11% +$4.04M 0.14% 177
2013
Q4 		$30.6M Sell
241,827
-86,551
-26% -$8.96M 0.12% 196
2013
Q3 		$30.2M Sell
328,378
-92,681
-22% -$7.48M 0.12% 193
2013
Q2 		$28.9M Buy
+421,059
New +$25.7M 0.12% 208

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Amundi Asset Management US's JAZZ Position: Q1 2021 in Review

Amundi Asset Management US increased its Jazz Pharmaceuticals (JAZZ) stake by 65% in Q1 2021, buying an estimated $6.32M and bringing the position to 97,625 shares worth $16M. The position accounts for 0.01% of the portfolio, ranked #728.

Amundi Asset Management US first reported a position in JAZZ in Q2 2013 and has held it in 32 quarters since. The position peaked at $130M in Q3 2017. 442 funds tracked by Wall St. Rank hold JAZZ as of Q1 2021.

  • Amundi Asset Management US held 97,625 shares of Jazz Pharmaceuticals worth $16M as of Q1 2021.
  • Amundi Asset Management US bought 38,380 Jazz Pharmaceuticals shares in Q1 2021, an estimated $6.32M.
  • Jazz Pharmaceuticals made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #728 holding.
  • Amundi Asset Management US first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 32 quarters since.
  • Amundi Asset Management US's Jazz Pharmaceuticals position peaked at $130M in Q3 2017.
  • 442 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.